Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Immunol Res ; 2022: 1810804, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35465350

RESUMEN

Methods: We analyzed the secretion of cytokines, chemokines, and growth factors in 22Rv1, LNCaP, and DU145 cells. In these cells, we also evaluated the expression of NK ligands, IL6R, STAT-3, and phosporylated STAT-3. In NK-92 cells, we evaluated the effects of Stattic (Stt) and tocilizumab (Tcz) on NK receptors. In addition, we assessed if the disruption of the IL6R/STAT-3 pathway and blockade of TIGIT potentiated the cytotoxicity of NK-92 cells versus DU145 cells. Results: DU145 abundantly secretes M-CSF, VEGF, IL-6, CXCL8, and TGF-ß. Furthermore, the expression of CD155 was found to increase in accordance with aggressiveness and metastatic status in the prostate cancer cells. Stt and Tcz induce a decrease in STAT-3 phosphorylation in the DU145 cells and, in turn, induce an increase of NKp46 and a decrease of TIGIT expression in NK-92 cells. Finally, the disruption of the IL6R/STAT-3 axis in prostate cancer cells and the blocking of TIGIT on NK-92 were observed to increase the cytotoxicity of NK-92 cells against DU145 cells through an increase in sFasL, granzyme A, granzyme B, and granulysin. Conclusions: Our results reveal that the combined use of inhibitors directed against the IL6R/STAT-3 axis and TIGIT enhances the functional activity of NK cells against castration-resistant prostate cancer cells.


Asunto(s)
Células Asesinas Naturales , Neoplasias de la Próstata , Humanos , Células Asesinas Naturales/metabolismo , Masculino , Próstata/metabolismo , Neoplasias de la Próstata/metabolismo , Receptores Inmunológicos/metabolismo , Receptores de Interleucina-6
2.
Int Immunopharmacol ; 93: 107341, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33486334

RESUMEN

Although acute stress generally exerts positive effects on the immune system, chronic stress typically causes immunosuppression via the hypothalamic-pituitary-adrenal (HPA) axis. In this study, the effects of capsaicin (1.28 mg/kg intraperitoneally [i.p.] for 7 days) on immune parameters were evaluated under conditions of chronic stress. Capsaicin treatment significantly increased the immune response as evaluated by the delayed-type hypersensitivity (DTH) reaction to dinitrofluorobenzene (DNFB) and splenocyte proliferation assays- It also is able to rescue the splenocytes of the apoptosis induced by stress. The capsaicin treatment increased the production of Th1 cytokines and decreased the production of Th2 cytokines and TGF-ß1 in the plasma and culture supernatants of immunosuppressed mice, which is associated with the modulation of Th2 induced by stress cells. Moreover, the production of corticosterone significantly decreased in capsaicin-treated animals as compared to control groups. The capsaicin treatment further attenuated the immunosuppression induced by the corticosterone treatment (40 mg/kg i.p. for 7 days), albeit less potently, as exhibited in the DTH response. Intriguingly, the capsaicin treatment decreased the induction of IL-10, IL-4, and TGF-ß1 through high doses of corticosterone, indicating direct cellular immunomodulation. These results show, that capsaicin is able to modulate chronic stress-induced immunosuppression, mediating corticosterone released inhibition, but also, that capsaicin significantly modulates the pharmacological action of corticosterone in vivo.


Asunto(s)
Capsaicina/farmacología , Tolerancia Inmunológica/efectos de los fármacos , Factores Inmunológicos/farmacología , Estrés Fisiológico/efectos de los fármacos , Animales , Proliferación Celular/efectos de los fármacos , Corticosterona/farmacología , Citocinas/sangre , Citocinas/inmunología , Dinitrofluorobenceno , Hipersensibilidad Tardía/inmunología , Masculino , Ratones Endogámicos BALB C , Bazo/citología , Estrés Fisiológico/inmunología , Factor de Crecimiento Transformador beta1/sangre , Factor de Crecimiento Transformador beta1/inmunología
3.
Clin Exp Immunol ; 204(1): 78-95, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33306195

RESUMEN

Immune checkpoint therapy to reverse natural killer (NK) and T cell exhaustion has emerged as a promising treatment in various cancers. While anti-programmed cell death 1 (PD-1) pembrolizumab has recently gained Food and Drug Administration (FDA) approval for use in recurrent or metastatic cervical cancer, other checkpoint molecules, such as T cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibition motif (ITIM) domains (TIGIT) and T cell immunoglobulin and mucin-domain containing-3 (Tim-3), have yet to be fully explored in this disease. We report expression of TIGIT, Tim-3 and PD-1 on subsets of peripheral blood NK (CD56dim/neg CD16bright/dim/neg and CD56bright CD16dim/neg ) and T cells. The percentages of these cells were increased in women with cervical cancer and pre-malignant lesions. PD-1+ NK and T cells were likely to co-express TIGIT and/or Tim-3. These cells, with an apparently 'exhausted' phenotype, were augmented in patients. A subset of cells were also natural killer group 2 member D (NKG2D)- and DNAX accessory molecule 1 (DNAM-1)-positive. PD-1int and PD-1high T cells were notably increased in cervical cancer. Soluble programmed cell death ligand 1 (PD-L1) was higher in cancer patient blood versus healthy donors and we observed a positive correlation between sPD-L1 and PD-1+ T cells in women with low-grade lesions. Within the cancer group, there were no significant correlations between sPD-L1 levels and cervical cancer stage. However, when comparing cancer versus healthy donors, we observed an inverse association between sPD-L1 and total T cells and a correlation between sPD-L1 and CD56dim NK cells. Our results may show an overview of the immune response towards pre-cancerous lesions and cervical cancer, perhaps giving an early clue as to whom to administer blocking therapies. The increase of multiple checkpoint markers may aid in identifying patients uniquely responsive to combined antibody therapies.


Asunto(s)
Antígeno B7-H1/metabolismo , Células Asesinas Naturales/metabolismo , Receptor de Muerte Celular Programada 1/metabolismo , Linfocitos T/metabolismo , Neoplasias del Cuello Uterino/metabolismo , Adulto , Antígenos de Diferenciación de Linfocitos T/metabolismo , Antígeno CD56/metabolismo , Femenino , Citometría de Flujo/métodos , Receptor 2 Celular del Virus de la Hepatitis A/metabolismo , Humanos , Células Asesinas Naturales/inmunología , Persona de Mediana Edad , Subfamilia K de Receptores Similares a Lectina de Células NK/metabolismo , Receptores Inmunológicos/metabolismo , Linfocitos T/inmunología , Neoplasias del Cuello Uterino/inmunología , Neoplasias del Cuello Uterino/patología , Adulto Joven
4.
Fish Shellfish Immunol ; 105: 8-15, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32629105

RESUMEN

The immune response of teleosts (bonefish) is altered by diazinon (DZN), an organophosphate pesticide. It has been suggested that such alteration is due to the extraneuronal cholinergic system in fish leukocytes that renders these cells a target of pesticides. Diazoxon (DZO), the oxon metabolite of DZN, has been attributed immunotoxic effects. Still, to date there are no reports on the effects of DZO upon parameters involved in the signaling cascade of immune response cells. Therefore, this work evaluated the effect of DZO on key parameters of cell signaling (intracellular Ca2+ flux, ERK 1/2 phosphorylation), cell proliferation, and antiproliferative processes (apoptosis, senescence, mitochondrial membrane potential) in spleen mononuclear cells of Nile tilapia fish. The results obtained show that DZO does not affect cell proliferation but causes a lack of response to stimulation with PMA and ionomycin to release intracellular calcium. In addition, it inhibits ERK 1/2 phosphorylation and causes loss of mitochondrial membrane potential, apoptosis, and senescence. These results suggest that the lack of cell response to release intracytoplasmic Ca2+ inhibits ERK which disrupts the mitochondrial membrane potential, leading to cell apoptosis and senescence. These findings prove that DZO significantly affects key parameters involved in the survival of immune response cells.


Asunto(s)
Muerte Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Cíclidos/inmunología , Insecticidas/toxicidad , Leucocitos Mononucleares/efectos de los fármacos , Compuestos Organofosforados/toxicidad , Transducción de Señal/efectos de los fármacos , Animales , Diazinón/metabolismo , Insecticidas/metabolismo , Masculino
5.
Fish Shellfish Immunol ; 89: 12-17, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30890431

RESUMEN

Diazinon (DZN) is an organophosphate pesticide characterized by inhibiting the enzyme acetylcholinesterase (AChE) (E.C. 3.1.1.7), affecting the nervous system. There is currently enough evidence proving this pesticide also affects the immune response; however, the immunotoxicity mechanisms through which these substances exerts toxic effects remain unclear. For that reason, this work evaluated the effect of diazinon on the intracellular calcium flux, ERK1/2 phosphorylation (pERK1/2), apoptosis, senescence, and mitochondrial membrane potential (ΔΨm) in spleen mononuclear cells (SMNC) of Nile tilapia, a teleost fish of commercial and ecological relevance. The results obtained indicate that diazinon causes significant damage in all evaluated parameters, which play an essential role in intracytoplasmic signaling of immune cells, suggesting these signal pathways could be related with the immunotoxicity mechanism of these type of pesticides.


Asunto(s)
Apoptosis/efectos de los fármacos , Cíclidos/fisiología , Diazinón/efectos adversos , Insecticidas/efectos adversos , Leucocitos/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Contaminantes Químicos del Agua/efectos adversos , Animales , Calcio/metabolismo , Senescencia Celular/efectos de los fármacos , Leucocitos/fisiología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Sistema de Señalización de MAP Quinasas/fisiología , Masculino , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Fosforilación/efectos de los fármacos , Bazo/efectos de los fármacos , Bazo/fisiología
6.
Fish Shellfish Immunol ; 84: 189-195, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30291982

RESUMEN

Organophosphorus pesticides (OPs) are broad-spectrum insecticides. One of the commonly used OPs is diazinon (DZN). The aim of this study was to evaluate the immunotoxic effect of DZN on phagocytic parameters of blood leukocytes using the teleost fish Oreochromis niloticus as a study model. For this purpose, fish were exposed in vivo to 0.97, 1.95 and 3.97 mg/L of DZN for 6 and 24 h. Our results indicated that phagocytic active cells decreased in fish exposed in vivo to 0.97 and 1.95 mg/L of DZN for 6 and 24 h. Regarding ROS production, H2O2 and O2- levels were higher on fish exposed to 1.95 mg/L for 6 and 24 h, while H2O2 production increased at 0.97 mg/L for 24 h. From this we can conclude that phagocytic parameters are sensitive to assess the effect of acute intoxication with organophosphorus pesticides on Nile tilapia.


Asunto(s)
Cíclidos/fisiología , Diazinón/efectos adversos , Insecticidas/efectos adversos , Leucocitos/efectos de los fármacos , Fagocitosis/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Estallido Respiratorio/efectos de los fármacos , Animales , Biomarcadores/sangre , Cíclidos/inmunología , Leucocitos/fisiología , Masculino , Contaminantes Químicos del Agua/efectos adversos
7.
Clin Transl Oncol ; 18(4): 369-74, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26329293

RESUMEN

PURPOSE: Pentoxifylline (PTX) has been shown to increase chemotherapy-induced apoptosis. A clinical trial was developed to evaluate the effect of the addition of PTX to the induction steroid window phase in children with acute lymphoblastic leukemia (ALL). METHODS: Thirty-two children were enrolled on this study. Children with a new diagnosis of ALL were randomly assigned to receive prednisone (PRD) 40 mg/m(2)/day only during the 7-day treatment pre-phase (PRD group, 11 patients) or to receive PRD with PTX (10 mg/kg/day) (PTX group, 11 patients); the control group included children with normal bone marrow (10 patients). Bone marrow aspiration (BMA) was performed at diagnosis (day -7) in all groups, and at day 0 (end of PRD window) for patients with ALL (PRD and PTX groups). Apoptosis was evaluated by flow cytometry (FC) using Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) stains. Statistical analysis was performed using the Mann-Whitney U test. RESULTS: Apoptotic index at day -7 was similar in all groups. However, at day 0 post-treatment, apoptosis was significantly higher in the PTX group than in the PRD group (p < 0.001). There were no serious adverse effects associated with PTX. CONCLUSIONS: PTX potentiates blast apoptosis induced by PRD in children with ALL during steroid window phase.


Asunto(s)
Apoptosis/efectos de los fármacos , Pentoxifilina/uso terapéutico , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Prednisona/uso terapéutico , Adolescente , Antiinflamatorios/uso terapéutico , Niño , Preescolar , Quimioterapia Combinada , Femenino , Citometría de Flujo , Estudios de Seguimiento , Depuradores de Radicales Libres/uso terapéutico , Humanos , Lactante , Masculino , Estadificación de Neoplasias , Proyectos Piloto , Leucemia-Linfoma Linfoblástico de Células Precursoras/patología , Pronóstico , Inducción de Remisión
8.
Lupus ; 25(6): 582-92, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26424128

RESUMEN

OBJECTIVE: B-cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) signaling pathways regulate B-cell survival through interactions with their receptors BAFF-R, TACI and BCMA. We evaluated the association of these ligands/receptors on B-cell subsets according to clinical manifestations of systemic lupus erythematosus (SLE). METHODS: BAFF and APRIL serum concentrations were measured in 30 SLE patients by enzyme-linked immunosorbent assay. The BAFF-R, TACI and BCMA expression was analyzed on each B cell subset (CD19 + CD27-CD38-/ + naïve; CD19 + CD27 + CD38-/ + memory; CD19 + CD27-CD38 + + immature and CD19 + CD27 + CD38 + + plasma cells) by flow cytometry, and compared among patients with different clinical manifestations as well as healthy controls (HCs). RESULTS: Serum BAFF and APRIL levels were high in SLE patients and correlated with the Mex-SLEDAI disease activity index (r = 0.584; p = 0.001 and r = 0.456; p = 0.011, respectively). The SLE patients showed an increased proportion of memory and plasma B cells (p < 0.05). BAFF-R, TACI and BCMA expression in SLE patients was decreased in almost all B cell subsets compared to HCs (p < 0.05). A lower BCMA expression was associated with severe disease activity, glomerulonephritis, serositis and hemolytic anemia (p < 0.01). BCMA expression showed a negative correlation with Mex-SLEDAI score (r = -0.494, p = 0.006). CONCLUSIONS: Decreased BCMA expression on peripheral B cells according to severe disease activity suggests that BCMA plays an important regulating role in B-cell hyperactivity and immune tolerance homeostasis in SLE patients.


Asunto(s)
Factor Activador de Células B/sangre , Subgrupos de Linfocitos B/metabolismo , Lupus Eritematoso Sistémico/fisiopatología , Miembro 13 de la Superfamilia de Ligandos de Factores de Necrosis Tumoral/sangre , Adolescente , Adulto , Anciano , Receptor del Factor Activador de Células B/genética , Antígeno de Maduración de Linfocitos B/genética , Estudios de Casos y Controles , Ensayo de Inmunoadsorción Enzimática , Femenino , Citometría de Flujo , Humanos , Tolerancia Inmunológica , Lupus Eritematoso Sistémico/inmunología , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Proteína Activadora Transmembrana y Interactiva del CAML/genética , Adulto Joven
9.
Chemotherapy ; 52(6): 308-15, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17008791

RESUMEN

BACKGROUND: Chemotherapy is effective against a wide variety of tumor cells, although its use is limited by side effects. In vitro experiments and phase I and II trials have shown that phytochemicals such as perillyl alcohol (P-OH) have antitumor effects. Pentoxifylline (PTX), a synthetic methylxanthine used mainly to treat pathologies associated with hematological diseases, sensitizes tumor cells to chemotherapy. The aim of this study was to determine whether PTX amplifies the antitumor effects of P-OH in U937 human myelomonocytic leukemia cells. METHODS: Apoptosis was measured by the loss of mitochondrial membrane potential determined by flow cytometry using dihexyloxacarbocyanine iodide (DiOC6) and propidium iodide. Bcl-2 and Bax protein expression was also assessed by Western blot analysis. RESULTS: P-OH and PTX induced loss of the mitochondrial membrane potential in U937 cells in vitro. Culturing the cells in the presence of both compounds caused a significant increase (p < 0.001) in apoptosis and expression of anti-apoptotic Bcl-2 and pro-apoptotic Bax proteins. However, despite their coexistence, Bax expression prevailed in our experiments. These data suggest that the effects of PTX might be attributable to changes in the mitochondrial membrane potential. CONCLUSION: PTX sensitizes tumor cells to the anti-neoplastic action of P-OH. These observations may have clinical relevance in the treatment of cancer patients.


Asunto(s)
Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Monoterpenos/farmacología , Pentoxifilina/farmacología , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteína X Asociada a bcl-2/metabolismo , Antineoplásicos/administración & dosificación , Biomarcadores de Tumor/metabolismo , Western Blotting , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/administración & dosificación , Citometría de Flujo , Humanos , Leucemia Mieloide/metabolismo , Leucemia Mieloide/fisiopatología , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Monoterpenos/administración & dosificación , Pentoxifilina/administración & dosificación , Células Tumorales Cultivadas , Células U937
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...